Taro Pharmaceutical Industries Ltd.
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Taro Pharmaceutical Industries Ltd.'s balance sheet done over the years? Its assets were worth $2,162,069,000 last year, which is more than in the previous period. 17% of Taro Pharmaceutical Industries Ltd.’s total assets is currently financed by debt. Its liabilities reached the amount of $369,063,000, which means an decrease by -9% compared compared to last year.
Debt to Assets
| 2015 | 1737745000 | 320.36M | 18.44% |
|---|---|---|---|
| 2016 | 2188033000 | 250.88M | 11.47% |
| 2017 | 2289753000 | 215.94M | 9.43% |
| 2018 | 2433210000 | 222.81M | 9.16% |
| 2019 | 2135326000 | 224.20M | 10.5% |
| 2020 | 2341252000 | 231.49M | 9.89% |
| 2021 | 2406873000 | 711.41M | 29.56% |
| 2022 | 2176361000 | 464.91M | 21.36% |
| 2023 | 2135513000 | 404.65M | 18.95% |
| 2024 | 2162069000 | 369.06M | 17.07% |
TARO Balance Sheet (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 362.90M | 154.49M | 251.13M | 605.17M | 513.35M | 567.45M | 576.61M | 600.39M | 576.75M | 481.64M |
Short term investments | 516.44M | 695.79M | 569.61M | 418.48M | 595.38M | 481.88M | 846.00M | 786.36M | 651.86M | 438.35M |
Net receivables | 177.46M | 241.80M | 306.69M | 266.88M | 270.78M | 285.30M | 329.42M | 470.20M | 509.33M | 473.33M |
Inventory | 204.81M | 226.66M | 210.43M | 180.29M | 153.07M | 148.07M | 144.59M | 141.04M | 138.55M | 120.27M |
Other current assets | 41.77M | 11.72M | 14.22M | 12.89M | 8.84M | 8.13M | 7.70M | 1.01M | 226.22M | 199K |
Total current assets | 1.30B | 1.33B | 1.33B | 1.47B | 1.53B | 1.48B | 1.89B | 1.99B | 1.87B | 1.51B |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 217.59M | 190.13M | 199.69M | 205.50M | 209.96M | 206.24M | 193.72M | 180.08M | 159.45M | 153.04M |
Goodwill | 17.23M | 17.23M | 11.82M | 7.19M | 7.19M | 7.19M | 7.20M | 7.19M | 7.19M | 7.20M |
Intangible assets | 0 | 76.14M | 60.12M | 19.78M | 21.66M | 22.33M | 20.80M | 19.86M | 22.37M | 13.20M |
Long term investments | 457.99M | 404.89M | 435.18M | 557.20M | 459.63M | 304.32M | 225.63M | 70.68M | 115.17M | 39K |
Other non-current assets | 82.45M | 83.14M | 6.76M | 4.33M | 3.50M | 1.54M | 1.95M | 2.57M | 2.22M | 46.29M |
Total non-current assets | 858.66M | 799.08M | 838.47M | 936.03M | 808.65M | 652.60M | 536.57M | 290.72M | 310.43M | 223.93M |
Total assets | 2.16B | 2.13B | 2.17B | 2.40B | 2.34B | 2.13B | 2.43B | 2.28B | 2.18B | 1.73B |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 903K | 5.78M | 7.58M | 237K | 9.43M | 3.22M | 167K | 799K | 79K |
Short term debt | 0 | 1.95M | 2.20M | 1.68M | 1.51M | 16.95M | -3.22M | 0 | -60.18M | 912K |
Total current liabilities | 361.10M | 385.54M | 432.11M | 676.30M | 222.73M | 216.82M | 215.75M | 209.83M | 245.46M | 310.00M |
| Non-current liabilities: | ||||||||||
Long term debt | 0 | 0 | 0 | -2.66M | -4.08M | -3.05M | -2.15M | 0 | -1.35M | -733K |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 7.95M | -616K | -919K | 1.57M | 2.74M | 1.48M | 297K | -1.63M | 27K | -983K |
Total non-current liabilities | 7.95M | 19.10M | 32.79M | 35.11M | 8.76M | 7.38M | 7.05M | 6.11M | 5.42M | 10.35M |
Total liabilities | 369.06M | 404.65M | 464.91M | 711.41M | 231.49M | 224.20M | 222.81M | 215.94M | 250.88M | 320.36M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |